Response to: Oba, Y. and Lone, N. (2013) Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. 7: 13–24.
Main Author: | Shahid Siddiqui |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-08-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465813489767 |
Similar Items
-
Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
by: Yuji Oba, et al.
Published: (2013-02-01) -
Roflumilast: A Review of Chronic Obstructive Pulmonary Disease (COPD) Treatment
by: Ita Octafia, et al.
Published: (2021-01-01) -
Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
by: Kim KH, et al.
Published: (2017-12-01) -
Potential treatment benefits and safety of roflumilast in COPD: a systematic review and meta-analysis
by: Yuan L, et al.
Published: (2016-06-01) -
GESTÃO DO TRABALHO E PARTICIPAÇÃO: CHEGA DE OBA-OBA?
by: Vanuza Bastos Rodrigues, et al.
Published: (2008-01-01)